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Abstract We have exposed human neutrophils to opsonized
Staphylococcus aureus and used an electrophoretic mobility shift
assay to show activation of the transcription factor NF-UB above
basal levels. Activation was evident within 10 min and was
increased with higher bacteria:neutrophil ratios. The neutrophil
NADPH oxidase inhibitor diphenylene iodonium, catalase, and
other oxidant scavengers did not inhibit NF-UB activation, and
no activation was seen with added hydrogen peroxide. Oxidants
produced during phagocytosis, therefore, are not involved in the
activation mechanism.
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1. Introduction
Nuclear factor UB (NF-UB) is a ubiquitous transcription
factor used extensively to regulate the expression of a range
of in£ammatory response genes [1^3]. Genes for tumor ne-
crosis factor (TNF), interleukin (IL) 1L, interleukin-1 receptor
antagonist, interleukin 8, granulocyte-macrophage colony
stimulating factor, the interleukin 2 receptor and some adhe-
sion molecules are among those with UB binding motifs in
their 5P regulatory region. Monocytes, macrophages and B
and T lymphocytes exploit the versatility of the NF-UB system
[1,2,4^6]. Neutrophils are terminally di¡erentiated cells with a
short circulating half-life. They have generally been consid-
ered only e¡ector cells rather than orchestrators of the im-
mune response. However, recent studies have shown that var-
ious soluble and particulate stimuli induce neutrophils to
transcribe and translate genes that encode in£ammatory me-
diators [7,8]. These include cytokines such as TNFK, IL-1L
and IL-8 and interleukin-1 receptor antagonist [9^14] that in
other cells are under the control of NF-UB. The potential for
neutrophils to use NF-UB as a transcription factor has been
identi¢ed by McDonald and coworkers [15,16] who demon-
strated NF-UB activation by several soluble stimuli and by
yeast particles. In contrast, Browning et al. [17] saw no acti-
vation. They concluded that this was due to insu⁄cient
amounts of NF-UB in the cytoplasm. NF-UB activation has
also been observed in monocytes and endothelial cells exposed
to micro-organisms or IgG aggregates [18,19].
NF-UB is a dimeric protein composed of members of the
Rel family of proteins. The predominant form encountered is
p50/RelA (p50/p65). NF-UB is sequestered in the cytoplasm in
an inactive state by an inhibitor protein, I-UB. Activation
requires dissociation of the transcription factor from its inhib-
itor and mobilisation to the nucleus, where it binds DNA
containing the UB motif to regulate transcription [20]. There
is substantial evidence that NF-UB is redox regulated
[3,21,22]. Although the mechanism is not fully understood,
activation appears to be in£uenced by the thiol oxidation state
of the cell, and endogenous generation of reactive oxygen
species following receptor-mediated activation has been pro-
posed [23^25]. In some cell types, hydrogen peroxide is able to
activate NF-UB directly [25^31].
Phagocytosis induces neutrophils to generate large amounts
of hydrogen peroxide and other reactive oxygen species [32].
These oxidants are potential mediators of NF-UB activation.
In this study, we have investigated whether NF-UB is acti-
vated in neutrophils during phagocytosis of Staphylococcus
aureus, and used inhibitors and scavengers of oxidants to
establish whether the mechanism involves oxidant generation.
2. Materials and methods
2.1. Reagents
Polyclonal rabbit antiserum raised against amino acids 3^19 of the
amino-terminal domain of RelA was purchased from Santa Cruz
Biotechnology (Santa Cruz, CA). UB probe, containing the NF-UB
binding site from HIV-1 LTR [33], was purchased from Life Tech-
nologies (Gaithersburg, MD). rhTNFK was supplied by Dr. J. Mi-
chaelis (Peptide Technology, Australia). All cell culture materials were
obtained from Life Technologies. Unless stated otherwise, biochemi-
cals were purchased from Sigma (St. Louis, MO). Complete protease
inhibitor, IFN-Q, and Klenow enzyme were obtained from Boehringer
Mannheim (Germany), and Ficoll and Hypaque from Pharmacia Bio-
technology (Uppsala, Sweden). K1-Antitrypsin was puri¢ed from hu-
man plasma [34]. Incubations were performed in phosphate bu¡er pH
7.4 containing 140 mM NaCl, 1 mM CaCl2, 0.5 mM MgCl2, and 5.6
mM glucose (Hanks’ bu¡er).
S. aureus ATCC 27217 (502a) was obtained from the New Zealand
Communicable Disease Centre, Porirua, New Zealand. The bacteria
were cultured overnight in nutrient broth then opsonized with 10%
plasma from the same donor as for the neutrophils. Zymosan was
heated in phosphate bu¡er pH 7.4 containing 140 mM NaCl for 20
min at 90‡C, followed by 20 min opsonisation at 37‡C in Hanks’
solution containing 33% plasma. Aggregated IgG was prepared as
in [35].
2.2. Neutrophil isolation and stimulation
Neutrophils were isolated from blood from healthy human donors
who had given informed consent, by Ficoll centrifugation, dextran
sedimentation and hypotonic lysis [36]. At least 95% of the cell prep-
aration consisted of neutrophils, with a viability of s 95% as deter-
mined by trypan blue exclusion. Neutrophils (3U106/ml) were treated
with the desired stimulus and incubated at 37‡C with gentle rotation.
S. aureus were incubated with neutrophils at a ratio of 20:1 [37].
Inhibitors were added to the cells 5 min prior to addition of the
stimulus. Reactions were stopped by placing the cells on ice.
2.3. Electrophoretic mobility shift assay
Whole cell extracts were prepared by pelleting the cells, washing in
Hanks’ bu¡er and resuspending in ice-cold lysis bu¡er (20 mM
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HEPES-KOH pH 7.5, 350 mM KCl, 1 mM MgCl2, 0.5 mM EDTA,
0.1 mM EGTA, 20% (v/v) glycerol, 1% (v/v) Nonidet P-40, 5 mM
DTT, and 1.6 mg/ml Complete protease inhibitor) for 15 min on ice.
Cell debris was pelleted at 14 000Ug for 20 min at 4‡C, and the
supernatant used for analysis. Total protein was determined using a
Bio-Rad assay (Bio-Rad Laboratories, Hercules, CA) according to the
manufacturer’s instructions using bovine serum albumin as standard.
The NF-UB DNA binding activity of extracts was determined by
electrophoretic mobility shift assay (EMSA) according to the method
of Zabel [33] except that Complete (1.5 mg/ml) was used in place of
the protease inhibitors. Extract containing a standard amount of pro-
tein (usually 10 Wg) was added to binding bu¡er to which KCl was
supplemented to a ¢nal concentration of 100 mM. For speci¢city
analysis, 100-fold excess of cold probe or 6 Wg RelApAb was included
in the binding reaction. Following a 10 min incubation on ice, 32P-
labelled probe was added and the solution left at room temperature
for 20 min. Samples were loaded on to a 4% polyacrylamide gel,
electrophoresed in 0.5UTris-borate-EDTA, and exposed to ¢lm using
an X-Omat intensifying screen (Kodak, USA). Band intensities were
determined using video densitometry and compared using SigmaStat
(Jandl Scienti¢c) either by paired t-test or ANOVA.
3. Results
To investigate whether NF-UB is activated during bacterial
ingestion, neutrophils were isolated from human blood and
incubated with S. aureus. Whole cell extracts were subjected
to EMSA with an oligonucleotide probe containing the con-
sensus UB binding sequence. Whole cell extracts from Wurz-
burg T cells that had been treated with hydrogen peroxide to
activate NF-UB [25] were used as a reference. The T cell ex-
tract gave two major bands in addition to free probe (Fig. 1,
lane 1), the slower of which was identi¢ed as NF-UB-speci¢c
on the basis of it being outcompeted by cold probe (not
shown) and supershifted by an antibody to the RelA subunit
(Fig. 2A, lane 9). Extracts from unstimulated neutrophils (Fig.
1, lane 2) gave a band with a faster mobility than the refer-
ence. This band (marked with an arrow) increased in intensity
when the neutrophils were incubated with opsonized S. aureus
(lane 3).
To determine whether the binding activity in the neutrophil
extracts represented NF-UB, several procedures were carried
out. This band was outcompeted by cold probe (Fig. 2A, lane
2) and decreased in intensity when the RelA antibody was
added (lane 3), although a supershift complex was not ob-
served. To determine whether degradation by neutrophil pro-
teases was responsible for the increase in mobility, K1-anti-
trypsin was included during preparation of cell extracts. This
procedure was adopted after Franzoso et al. [38] showed that
NF-UB in extracts in subclones of U937 promyelocytic cells
underwent proteolysis during processing to give a fast band.
This was not prevented by standard inhibitor cocktails, but
high concentrations of the serine protease inhibitor K1-anti-
trypsin gave normal mobility. Addition of 3 mg/ml K1-anti-
trypsin to neutrophil extracts gave two di¡use electrophoretic
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Fig. 1. EMSA detection of binding activity in whole cell extracts
from neutrophils exposed to S. aureus, using an NF-UB-speci¢c oli-
gonucleotide probe. Lane 1: Reference NF-UB. Whole cell extract
from Wurzburg T cells activated with 100 WM hydrogen peroxide as
in [25]. Lane 2: Neutrophils plus S. aureus at a 1:20 ratio, placed
on ice immediately after mixing. Lane 3: As in lane 2 but incubated
for 30 min at 37‡C. The faster moving UB-speci¢c band in the neu-
trophil extracts is designated with an arrow and the band corre-
sponding to the RelA/p50 complex in the T cell reference sample is
shown by an asterisk. The other major band shown (NS) is not
shifted by the cold probe and is non-speci¢c. The lower section of
the gel containing free probe is not shown.
Fig. 2. A: Identi¢cation of neutrophil band as NF-UB. Lane 1: Ex-
tract from stimulated neutrophils. Lane 2: Extract from lane 1 with
cold probe added. Lane 3: Extract from lane 1 with anti-RelA anti-
body added. Lanes 4^6: Same as lanes 1^3, but with K1-antitrypsin
(3 mg/ml) added to the cell lysis bu¡er. Lane 7: Same as lane 6 but
with 3 times as much protein loaded. Lane 8: Reference NF-UB
from Wurzburg T cells plus hydrogen peroxide. Lane 9: Same as
lane 8 with anti-RelA added. EMSA was performed as in Fig. 1, ex-
cept that the cell extract was obtained from neutrophils following
incubation with 5 mg/ml opsonized zymosan. Bands are identi¢ed
as in Fig. 1, with the supershifted band marked by an arrowhead.
B: Premixing of cell extracts from neutrophils and Wurzburg T cells
to show degradation of NF-UB in the latter by neutrophil proteases.
Conditions as in A. Lane 1: Neutrophil extract after activation with
opsonized zymosan. Lane 2: Wurzburg cell extract. Lane 3: Both
extracts mixed at room temperature for 10 min before performing
EMSA.
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bands (Fig. 2A, lane 4), one in the same position as in the
control sample and the other with the same mobility as T cell
NF-UB (lane 8). Both bands were outcompeted by cold probe
(lane 5) and decreased in intensity by the RelA antibody (lane
6). With a higher loading of the antibody-treated extract, a
faint supershift complex was observed (lane 7) with the same
mobility as supershifted T cell NF-UB (lane 9).
Con¢rmation of proteolytic degradation was obtained by
co-incubating extracts from activated T cells and neutrophils
for a brief period (Fig. 2B). Only one NF-UB band with sim-
ilar mobility to neutrophil NF-UB was observed. These results
indicate that although proteolysis in neutrophil extracts leads
to a faster electrophoretic band, this band is nonetheless spe-
ci¢c for NF-UB. Since blocking proteolysis required large
amounts of K1-antitrypsin, and even then was only partially
e¡ective, subsequent experiments were performed using only
the standard inhibitor cocktail and changes in the faster band
were assessed.
We always observed some NF-UB activation in unstimu-
lated neutrophils. This was already present in the isolated
cells, as further incubation did not increase the level of activ-
ity. Although the basal level of activity varied between prep-
arations and in some cases obscured any e¡ect of the bacteria,
the results of all the experiments performed showed a signi¢-
cant increase in NF-UB binding: 10^60 min exposure to S
aureus gave a 1.40-fold increase in NF-UB band intensity
above control, S.E. = 0.06, n = 34, P6 0.001. Activation of
NF-UB depended on the number of bacteria added. It was
scarcely above background with a 1:1 S. aureus to neutrophil
ratio, but increased progressively with ratios of 5:1 to 50:1
(Fig. 3A). Most of the activation occurred during the early
stages of a 1 h incubation (Fig. 3B).
Since phagocytic stimuli induce neutrophils to undergo an
oxidative burst, we tested whether oxidants were responsible
for the NF-UB activation in neutrophils incubated with S.
aureus. The addition of diphenylene iodonium, which inhibits
the NADPH oxidase and gives less than 5% normal super-
oxide production [37], or catalase to scavenge hydrogen per-
oxide, had no e¡ect on the degree of stimulation (Fig. 4). In
other experiments, addition of superoxide dismutase, or me-
thionine to scavenge myeloperoxidase-derived hypochlorous
acid, gave no inhibition. Consistent with the lack of inhibition
by oxidant scavengers, exogenous hydrogen peroxide added to
neutrophils gave no NF-UB activation over a 1 h period (Fig.
4).
To determine whether phagocytosing neutrophils release a
stable factor that could activate NF-UB in neighboring cells,
neutrophils were incubated with opsonized zymosan for 30
min, then the supernatant was removed and added to fresh
neutrophils. Analysis by EMSA showed a strong NF-UB band
in the cells exposed to zymosan, but activation in the fresh
neutrophils was no higher than in cells incubated in Hanks’
bu¡er alone (not shown).
Other stimuli were tested. Increased binding to the probe
was observed when the neutrophils were incubated with
opsonized zymosan (5 mg/ml) or with aggregated IgG (0.5
mg/ml) suggesting NF-UB activation. However, cell extracts
prepared immediately after adding these phagocytic stimuli
showed increased DNA binding activity, so whether this rep-
resents true activation is uncertain. TNFK and LPS gave small
increases in binding activity, observed after 1 h. No increase
over unstimulated cells was seen with phorbol myristate ace-
tate (PMA), the calcium ionophore A23187, interferon Q,
granulocyte colony stimulating factor or f-Met-Leu-Phe. In-
cubation of the cells in RPMI as against Hanks’ solution gave
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Fig. 3. EMSA of neutrophil extracts showing NF-UB activation
with opsonised S. aureus. A: Dependence on number of bacteria
added. Assays were performed 30 min after mixing. Ratios of bac-
teria:neutrophils are shown above each lane. B: Time course of ac-
tivation with bacteria:neutrophil ratio of 20:1. The ¢rst lane shows
background activation with no bacteria after 30 min. Incubation
times in minutes are shown above the other lanes. For the zero
time sample, cells were cooled on ice immediately after mixing. In
each case, the results are from one of two experiments performed
with di¡erent neutrophil donors. Both gave similar results. The por-
tion of the gel showing the neutrophil NF-UB band is shown.
Fig. 4. E¡ect of oxidant inhibitors and scavengers on neutrophil
NF-UB activation by S. aureus determined by video densitometry.
Neutrophils (3U106) were incubated for 30 min with S. aureus
(6U107) and, where indicated, 10 WM diphenylene iodonium (DPI),
20 Wg/ml catalase or 100 WM hydrogen peroxide. Results are means
þ S.E.M. of ¢ve experiments. Band intensities were not signi¢cantly
di¡erent in cells exposed to bacteria with or without DPI or cata-
lase, and all were signi¢cantly higher than the unstimulated control
(P6 0.05, ANOVA). Hydrogen peroxide treatment was not signi¢-
cantly di¡erent from controls.
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no apparent di¡erence in the degree of activation observed
with any stimulus (results not shown).
4. Discussion
We have shown that NF-UB can be activated in neutrophils
following phagocytosis of S. aureus. Activation, detected by
EMSA with a UB-speci¢c probe, was evident within 10 min. It
was more pronounced at the higher bacteria to neutrophil
ratios. This is the ¢rst report of NF-UB activation in neutro-
phils by live bacteria. Our ¢ndings extend those of McDonald
et al. [16] who saw activation in neutrophils exposed to heat-
killed yeast. The modest activation we saw with TNFK or LPS
but not other soluble stimuli also agrees more with the ¢nd-
ings of McDonald et al. [15], rather than with Browning et al.
[17] who reported no activation. In the former study the p50
and RelA subunits were shown to be present in neutrophils.
Initially they were predominantly cytoplasmic, but on stimu-
lation, degradation of I-UB and migration into the nucleus
was observed.
The increase in NF-UB activity over background caused by
bacterial ingestion was signi¢cant but relatively modest. This
may be a consequence of some cell preparations already show-
ing substantial activity rather than necessarily indicating a low
response to the stimulus. Alternatively, only a subset of the
cells may respond. The activity observed in extracts from
freshly isolated neutrophils could represent constitutive NF-
UB in circulating neutrophils. However, others found less
background activity in extracts of neutrophils lysed by nitro-
gen cavitation [15], implying that it mainly occurs during
processing.
An unusual ¢nding was that the neutrophil NF-UB complex
observed by EMSA had a faster mobility than the p50/RelA
complex in T cell extracts. Our results with added K1-anti-
trypsin and with mixing T cell and neutrophil extracts show
that this was due to rapid proteolytic cleavage by a constitu-
ent of the neutrophil extract. Similar ¢ndings have been re-
ported by Franzoso et al. [38] for some U937 subclones. They
inhibited degradation with K1-antitrypsin or di-isopropyl-
£uorophosphate (DFP), and McDonald et al. [15,16] routinely
used DFP when preparing neutrophil extracts. Since antibody
binding is abolished during proteolysis, it appears that the C-
terminus containing the activation domain of RelA is cleaved.
The concentrations of K1-antitrypsin required to partially in-
hibit degradation are higher than would be needed to inhibit
the major neutrophil serine proteases, elastase and cathepsin
G. Speci¢c inhibitors of these enzymes were also ine¡ective
(not shown). This suggests that neutrophils contain a serine
protease that has a high reactivity towards RelA. If this pro-
tease were present in the cytoplasm, it could abrogate any
e¡ects of NF-UB activation. However, it is more likely to be
one of the granule proteases released during processing.
Since oxidants have been shown to activate NF-UB activa-
tion in other cells, the large amounts of superoxide, hydrogen
peroxide and hypochlorous acid generated during phagocyto-
sis could provide the trigger for activation in neutrophils. We
found that inhibiting the oxidative burst with diphenylene
iodonium or adding oxidant scavengers did not inhibit acti-
vation. Furthermore, hydrogen peroxide added exogenously
did not activate the cells. There is also no correlation between
the extent to which soluble stimuli induce superoxide produc-
tion and their ability to activate NF-UB. We conclude, there-
fore, that activation of NF-UB in neutrophils does not occur
by an oxidative mechanism. The situation appears to be di¡er-
ent with alveolar macrophages, which showed catalase-sensi-
tive NF-UB activation by PMA and activation by hydrogen
peroxide [31].
It is generally considered that once neutrophils have phag-
ocytosed bacteria, they have performed their function and are
destined for death. Indeed, a few hours after stimulation they
show changes associated with apoptosis [39,40]. It is intrigu-
ing, therefore, that a transcription factor is activated in these
cells. We reasoned that it might be advantageous for phago-
cytosing cells to release a factor that could regulate transcrip-
tion in adjacent cells, but no soluble activator of NF-UB was
detected. In£ammatory molecules such as TNFK and IL-8 are
transcriptionally regulated by NF-UB and are synthesised in
neutrophils following phagocytosis [9,10]. Whether NF-UB
activates transcription in cells containing ingested bacteria,
and if so for what purpose, are questions that require further
investigation.
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